Post-transplant lymphoproliferative disorders of oral cavity

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 105, Issue 5, 2008, Pages 589-596

  Ojha, Junu ^a   Islam, Nadim ^b   Cohen, Donald M ^c   Marshal, David ^d   Reavis, Michael R ^e   Bhattacharyya, Indraneel ^c  

^a UNIVERSITY OF DETROIT MERCY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^d Oral and Maxillofacial Surgery   (United States)

^e Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CHILD; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; MOUTH DISEASE; PANCREAS TRANSPLANTATION; VIROLOGY; VIRUS INFECTION;

ADULT; CHILD; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MOUTH DISEASES; PANCREAS TRANSPLANTATION;

EID: 42949135862     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.11.028     Document Type: Article

References (33)

1. Nalesnik M.A., Makowka L., and Starzl T.E. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 25 (1988) 367-472
2. Dean A.F., Diss T.C., Wotherspoon A.C., Cox T., and Nevard C. Histologic, molecular, and radiologic characterization of resolving cerebral posttransplant lymphoproliferative disorder. Pediatr Res 41 (1997) 651-656
3. Lones M.A., Mishalani S., Shintaku I.P., Weiss L.M., Nichols W.S., and Said J.W. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol 26 (1995) 525-530
4. Chang H., Wu J.D., Cheng K.K., and Tseng H.H. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case. Formos Med Assoc 93 (1994) 332-336
5. Shroff R., and Rees L. The post-transplant lymphoprolipherative disorder-a literature review. Pediatr Nephrol 19 (2004) 369-377
6. Dharnidharka V.R., Tejani A.H., Ho P.L., and Harmon W.E. Post-transplant lymphoproliferative disorder in the United States young caucasian males are at highest risk. Am J Transplant 2 (2002) 993-998
7. van Gorp J., Doornewaard H., Verdorck L., Klöpping C., Vos P.F., and van den Tweel J.G. Posttransplant T cell lymphoma: report of three cases and a review of the literature. Cancer 73 (1994) 3064-3072
8. Bierman P.J., Vose J.M., Langnas A.N., Rifkin R.M., Hauke R.J., Smir B.N., et al. Hodgkin's disease following solid organ transplantation. Ann Oncol 7 (1996) 265-270
9. Starzl T.E. Five years experience with renal transplantation with immunosuppressive drugs: survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula. In discussion of: Murray JE, Wilson RE, Tilney NL, et al. Ann Surg 168 (1968) 416
10. Morrison V.A., Dunn D.L., Manivel J.C., Gajl-Peczalska K.J., and Peterson B.A. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97 (1994) 14-24
11. Swerdlow S.H. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol 14 (1997) 2-7
12. Basgoz N., and Preiksaitis J.K. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am 9 (1995) 901-923
13. Walker R.C., Paya C.V., Marshall W.F., Strickler J.G., Wiesner R.H., Velosa J.A., et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 14 (1995) 214-221
14. Pickhardt P.J., Siegel M.J., RHayashi R.J., and Kelly M. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features. Radiology 217 (2000) 16-25
15. Shapiro R., Nalesnik M., McCauley J., Fedorek S., Jordan M.L., Scantelbury V.P., et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant recipients receiving tacrolimus based immunosuppression. Transplantation 68 (1999) 1851-1854
16. Ho M., Jaffe R., and Miller G. The frequency of Epstein Barr virus infection and associated lymphoproliferative disease after transplantation and its manifestations in children. Transplantation 45 (1988) 719-724
17. Haque T., Thomas J.A., Falk K.I., Parratt R., Hunt B.J., Yacoub M., and Crawford D.H. Transfer of donor EBV in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Virol 77 (1996) 1169-1172
18. Hsieh W.S., Lemas M.V., and Ambinder R.F. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease. Transpl Infect Dis 1 (1999) 204-212
19. Paya C.V., Fung J.J., Nalesnik M.A., Kieff E., Green M., Gores G., et al. Epstein Barr virus induced posttransplant lymphoproliferative disorders. Transplantation 68 (1999) 1517-1525
20. Nalesnik M.A. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 8 (1996) 139-148
21. LaCasce A.S. Post-transplant lymphoproliferative disorders. Oncologist 6 (2006) 674-680
22. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia. Histopathology 361 (2000) 69-86
23. Harris N.L., Ferry J.A., and Swerdlow S.H. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology workshop. Semin Diagn Pathol 14 (1997) 8-14
24. Nalesnik M.A. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD). Springer Semin Immunopathol 20 (1998) 325-342
25. Srivastava T., Zwick D.L., Rothberg P.G., and Warady B.A. Post-transplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol 13 (1999) 748-754
26. Starzl T.E., Nalesnik M.A., and Porter K.A. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet I (1984) 583-587
27. Cockfield S.M. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3 (2001) 70-78
28. Dharnidharkar V.R., Ho P.l., Stablein D.M., Harmon W.E., and Tejani A.H. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Paediatric Renal Transplant Cooperative Study. Pediatr Transpl 5 (2002) 396-399
29. Hanto D.W., Frizzera G., Purtilo D.T., Sakamoto K., Sullivan J.L., Saemundsen A.K., et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 11 (1981) 4253-4261
30. Raut A., Huryn J., Pollack A., and Zlotolow I. Unusual gingival presentation of post- transplantation lymphoproliferative disorder: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 436-441
31. Oda D., Persson G.R., Haigh W.G., Sabath D.E., Penn I., and Aziz S. Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation. Transplantation 61 (1996) 435-440
32. Broudy V.C., and Sabath D.E. Posttransplantation lymphoproliferative gingival disease. Blood 86 (1995) 2891
33. Johnson J., Kerecuk L., Harrison M., Taylor J.O., and Odell E. Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report. Pediatr Transpl 11 (2007) 340-344